Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?
Open Access
- 13 August 2013
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 109 (5) , 1147-1156
Abstract
Despite multidisciplinary tumour boards (MTBs), non-compliance with clinical practice guidelines is still observed for breast cancer patients. Computerised clinical decision support systems (CDSSs) may improve the implementation of guidelines, but cases of non-compliance persist. OncoDoc2, a guideline-based decision support system, has been routinely used to remind MTB physicians of patient-specific recommended care plans. Non-compliant MTB decisions were analysed using a multivariate adjusted logistic regression model. Between 2007 and 2009, 1624 decisions for invasive breast cancers with a global non-compliance rate of 8.3% were analysed. Patient factors associated with non-compliance were age>80 years (odds ratio (OR): 7.7; 95% confidence interval (CI): 3.7–15.7) in pre-surgical decisions; microinvasive tumour (OR: 5.2; 95% CI: 1.5–17.5), surgical discovery of microinvasion in addition to a unique invasive tumour (OR: 4.2; 95% CI: 1.4–12.5), and prior neoadjuvant treatment (OR: 4.2; 95% CI: 1.1–15.1) in decisions with recommendation of re-excision; age<35 years (OR: 4.7; 95% CI: 1.9–11.4), positive hormonal receptors with human epidermal growth factor receptor 2 overexpression (OR: 15.7; 95% CI: 3.1–78.7), and the absence of prior axillary surgery (OR: 17.2; 95% CI: 5.1–58.1) in adjuvant decisions. Residual non-compliance despite the use of OncoDoc2 illustrates the need to question the clinical profiles where evidence is missing. These findings challenge the weaknesses of guideline content rather than the use of CDSSs.Keywords
This publication has 50 references indexed in Scilit:
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)The Lancet Oncology, 2012
- Variability in Reexcision Following Breast Conservation SurgeryJAMA, 2012
- Surgical treatment of early stage breast cancer in elderly: an international comparisonBreast Cancer Research and Treatment, 2011
- Discordance With Local Guidelines for Adjuvant Chemotherapy in Breast Cancer: Reasons and Effect on SurvivalClinical Breast Cancer, 2011
- Cancer Multidisciplinary Team Meetings: Evidence, Challenges, and the Role of Clinical Decision Support TechnologyInternational Journal of Breast Cancer, 2011
- Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort studyAnnals of Oncology, 2009
- The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2Nature Clinical Practice Oncology, 2008
- Supporting multidisciplinary staff meetings for guideline-based breast cancer management: a study with OncoDoc2.2007
- Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast CancerJournal of Clinical Oncology, 2004
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999